Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in Advanced NSCLC With Asymptomatic Brain Metastasis
NCT00614809Phase 2Unknown
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Dec 2007
- Primary completion
- Mar 2010
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of gefitinib in non-small cell lung cancer (NSCLC), sponsored by Guangdong Provincial People's Hospital. Status: unknown.
02
Drugs
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00614809.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00614809.